Cargando…
The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Academy of Managed Care Pharmacy
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391150/ https://www.ncbi.nlm.nih.gov/pubmed/34464211 http://dx.doi.org/10.18553/jmcp.2021.27.9.1321 |
| _version_ | 1785082638858452992 |
|---|---|
| author | Jensen, Chelsee |
| author_facet | Jensen, Chelsee |
| author_sort | Jensen, Chelsee |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10391150 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Academy of Managed Care Pharmacy |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-103911502023-08-02 The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable Jensen, Chelsee J Manag Care Spec Pharm Perspectives on Value Academy of Managed Care Pharmacy 2021-09 /pmc/articles/PMC10391150/ /pubmed/34464211 http://dx.doi.org/10.18553/jmcp.2021.27.9.1321 Text en Copyright © 2021, Academy of Managed Care Pharmacy. All rights reserved. https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits unrestricted use and redistribution provided that the original author and source are credited. |
| spellingShingle | Perspectives on Value Jensen, Chelsee The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title | The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title_full | The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title_fullStr | The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title_full_unstemmed | The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title_short | The high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| title_sort | high cost burden of third- to fifth-line treatments for multiple myeloma: unsustainable and unaffordable |
| topic | Perspectives on Value |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10391150/ https://www.ncbi.nlm.nih.gov/pubmed/34464211 http://dx.doi.org/10.18553/jmcp.2021.27.9.1321 |
| work_keys_str_mv | AT jensenchelsee thehighcostburdenofthirdtofifthlinetreatmentsformultiplemyelomaunsustainableandunaffordable AT jensenchelsee highcostburdenofthirdtofifthlinetreatmentsformultiplemyelomaunsustainableandunaffordable |